Citius Pharmaceuticals In... (CTXR)
NASDAQ: CTXR
· Real-Time Price · USD
1.23
-0.15 (-10.87%)
At close: Aug 19, 2025, 3:59 PM
1.29
5.31%
After-hours: Aug 19, 2025, 07:59 PM EDT
Citius Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
October - September.
| Fiscal Year | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
Revenue | 155.93K | 155.93K | 155.93K | 155.93K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 266.77K | 319.62K | 315.68K | 311.85K | 205.9K | 202.06K | 149.99K | 146.17K | 142.45K | 138.78K | 183.25K | 179.68K | 176.19K | 172.53K | 168.65K | 125.04K | 82.28K | 40.59K | n/a |
Gross Profit | -110.84K | -163.69K | -159.75K | -155.93K | -205.9K | -202.06K | -149.99K | -146.17K | -142.45K | -138.78K | -183.25K | -179.68K | -176.19K | -172.53K | -168.65K | -125.04K | -82.28K | -40.59K | n/a |
Operating Income | -32.35M | -42.98M | -42.69M | -42M | -41.07M | -39.11M | -38.82M | -36.73M | -34.16M | -34.4M | -31.31M | -33.32M | -30.97M | -28.04M | -24.63M | -23.53M | -22.47M | -21.17M | -21.42M |
Interest Income | 173.97K | 358.18K | 526.97K | 758K | 965.5K | 1.1M | 1.22M | 1.18M | 989.43K | 705.67K | 431.97K | 251.4K | 192.17K | 242.57K | 282.32K | 261.82K | 209.83K | 119.43K | 62.21K |
Pretax Income | -41.14M | -42.63M | -39.78M | -38.85M | -37.72M | -35.62M | -37.6M | -31.97M | -29.58M | -30.11M | -27.29M | -33.06M | -30.61M | -27.57M | -24.13M | -23.05M | -22.21M | -21.07M | -21.37M |
Net Income | -41.27M | -42.64M | -39.68M | -39.14M | -38.29M | -36.2M | -38.18M | -32.54M | -30.59M | -30.92M | -27.93M | -33.56M | -30.53M | -27.54M | -24.13M | -23.05M | -22.21M | -21.07M | -21.37M |
Selling & General & Admin | 22.76M | 26.19M | 28.76M | 30.09M | 29.2M | 26.23M | 24.83M | 21.91M | 18.36M | 17.48M | 15.66M | 15.66M | 14.88M | 14.63M | 13.13M | 11.29M | 11.04M | 9.3M | 9.08M |
Research & Development | 10.43M | 11.57M | 11.41M | 11.91M | 11.87M | 12.88M | 14M | 14.82M | 15.79M | 16.92M | 15.64M | 17.66M | 16.09M | 13.41M | 11.51M | 12.24M | 11.43M | 11.87M | 12.34M |
Other Expenses | 7.95M | 5.23M | 2.52M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 59.92K | 59.92K | 59.92K | 59.92K | n/a | n/a |
Operating Expenses | 41.14M | 42.98M | 42.64M | 41.94M | 41.02M | 39.06M | 38.82M | 36.73M | 34.16M | 34.4M | 31.31M | 33.32M | 30.97M | 28.04M | 24.63M | 23.53M | 22.47M | 21.17M | 21.42M |
Interest Expense | -172.26K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.93K | 6.87K | 10.84K | 14.3K | 15.61K | 15.65K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 32.35M | 42.98M | 42.69M | 42M | 41.07M | 39.11M | 38.82M | 36.73M | 34.16M | 34.4M | 31.31M | 33.32M | 30.97M | 28.04M | 24.63M | 23.53M | 22.47M | 21.17M | 21.42M |
Income Tax Expense | 936.72K | 816.48K | 696.24K | 576K | 576K | 576K | 576K | 576K | 1.01M | 810.98K | 637.41K | 527.39K | -48.61K | 4.41K | 33.98K | 13.48K | 37.09K | 50.1K | 62.21K |
Shares Outstanding (Basic) | 11.01M | 11.59M | 11.59M | 11.59M | 11.59M | 10.6M | 10.6M | 10.59M | 10.25M | 9.75M | 9.75M | 9.74M | 9.74M | 9.74M | 9.73M | 9.73M | 9.14M | 6.4M | 3.71M |
Shares Outstanding (Diluted) | 11.01M | 11.59M | 11.59M | 11.59M | 11.59M | 10.6M | 10.6M | 10.59M | 10.25M | 9.75M | 9.75M | 9.74M | 9.74M | 9.74M | 9.73M | 9.76M | 9.14M | 6.4M | 3.71M |
EPS (Basic) | -3.43 | -2.69 | -1.48 | -0.23 | -0.24 | -0.23 | -0.25 | -0.21 | -0.21 | -0.21 | -0.19 | -0.23 | -0.21 | -0.19 | -0.18 | -0.27 | -0.35 | -0.41 | -0.5 |
EPS (Diluted) | -3.43 | -2.69 | -1.48 | -0.23 | -0.24 | -0.23 | -0.25 | -0.21 | -0.21 | -0.21 | -0.19 | -0.23 | -0.21 | -0.19 | -0.18 | -0.27 | -0.35 | -0.41 | -0.5 |
EBITDA | -32.17M | -42.75M | -42.53M | -41.89M | -41.02M | -39.11M | -38.77M | -36.68M | -33.93M | -34.07M | -30.95M | -32.88M | -30.43M | -27.4M | -23.96M | -22.88M | -22.04M | -20.9M | -21.2M |
EBIT | -32.34M | -42.97M | -42.69M | -42M | -41.07M | -39.11M | -38.82M | -36.73M | -34.02M | -34.27M | -31.17M | -33.18M | -30.73M | -27.63M | -24.16M | -23.04M | -22.2M | -21.05M | -21.36M |
Depreciation & Amortization | 164.53K | 217.38K | 213.44K | 209.61K | 205.9K | 202.06K | 198.14K | 194.32K | 190.6K | 186.93K | 183.25K | 179.68K | 176.19K | 172.53K | 168.65K | 164.87K | 161.23K | 150.58K | 157.44K |